Ogita Manabu, Sakakura Kenichi, Nakamura Tomohiro, Funayama Hiroshi, Wada Hiroshi, Naito Ryo, Sugawara Yoshitaka, Kubo Norifumi, Ako Junya, Momomura Shin-ichi
Cardiovascular Division, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya, Saitama, Saitama 330-8503, Japan.
Heart Vessels. 2012 Sep;27(5):460-7. doi: 10.1007/s00380-011-0177-6. Epub 2011 Aug 6.
Acute renal insufficiency after percutaneous coronary artery intervention (PCI) is a strong predictor of adverse events. However, the effect of chronic renal impairment on the long-term outcomes after PCI has not been well established. The aim of this study was to evaluate the incidence of deteriorated renal function during the chronic phase after PCI and its impact on clinical outcomes. We enrolled 282 consecutive patients who underwent PCI and had serum creatinine measured during the chronic phase (at least 3 months after PCI). We divided the study population into two groups: an advanced group that had an increase in stage of chronic kidney disease during the chronic phase, and a preserved group that included the remainder of the study population. There were 43 patients in the advanced group. We evaluated the incidence of major adverse cardiac events (MACE) that included all-cause death, nonfatal myocardial infarction, and rehospitalization with heart failure or angina pectoris. The rate of rehospitalization for heart failure and angina pectoris was significantly higher in the advanced group than in the preserved group (19.0% vs 6.8%, P < 0.01). In multivariate Cox regression analysis, the advanced group was associated with MACE (hazard ratio 3.50, 95% confidence interval 1.49-8.22, P < 0.01). Deterioration of renal function during long-term follow-up after percutaneous coronary intervention was associated with adverse cardiac events.
经皮冠状动脉介入治疗(PCI)后急性肾功能不全是不良事件的有力预测指标。然而,慢性肾功能损害对PCI术后长期预后的影响尚未明确。本研究的目的是评估PCI术后慢性期肾功能恶化的发生率及其对临床结局的影响。我们纳入了282例连续接受PCI且在慢性期(PCI术后至少3个月)测量血清肌酐的患者。我们将研究人群分为两组:慢性期慢性肾脏病分期增加的进展组,以及包括其余研究人群的保留组。进展组有43例患者。我们评估了主要不良心脏事件(MACE)的发生率,包括全因死亡、非致命性心肌梗死以及因心力衰竭或心绞痛再次住院。进展组心力衰竭和心绞痛的再次住院率显著高于保留组(19.0%对6.8%,P<0.01)。在多变量Cox回归分析中,进展组与MACE相关(风险比3.50,95%置信区间1.49 - 8.22,P<0.01)。经皮冠状动脉介入治疗后长期随访期间肾功能恶化与不良心脏事件相关。